Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives
Open accessThe DOI matches its Crossref record; 187 of the 189 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Stroke is the second leading cause of death and a major contributor to disability worldwide. The prevalence of stroke is highest in developing countries, with ischemic stroke being the most common type. Considerable progress has been made in our understanding of the pathophysiology of stroke and the underlying mechanisms leading to ischemic insult. Stroke therapy primarily focuses on restoring blood flow to the brain and treating stroke-induced neurological damage. Lack of success in recent clinical trials has led to significant refinement of animal models, focus-driven study design and use of new technologies in stroke research. Simultaneously, despite progress in stroke management, post-stroke care exerts a substantial impact on families, the healthcare system and the economy. Improvements in pre-clinical and clinical care are likely to underpin successful stroke treatment, recovery, rehabilitation and prevention. In this review, we focus on the pathophysiology of stroke, major advances in the identification of therapeutic targets and recent trends in stroke research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“UMNDs may occur because of a traumatic event, nontraumatic event, or inherited or sporadic neurodegenerative disease.1,3–8”
From Feasibility, Acceptability, and Efficacy of Mindfulness Training in People With Upper Motor Neuron Disorders: A Systematic Review (2022) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedTissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266 · cited 1×
“In one study, a blood pressure (BP) of at least 160/90 mmHg and a history of hypertension were considered equally important predispositions for stroke, with 54% of the stroke-affected population having these characteristics [42,43].”
BackgroundHeart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388 · cited 1×
“Atrial fibrillation (AF): AF is an important risk factor for stroke, increasing risk two- to five-fold depending upon the age of the individual concerned [50].”
BackgroundIntravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149 · cited 1×
“Primary (first-time) hemorrhages comprise the majority of strokes, with secondary (second-time) hemorrhages constituting an estimated 10–25% [2,3].”
BackgroundBlood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491 · cited 1×
“A study reported that a 5–6 mm Hg reduction in BP lowered the relative risk of stroke by 42% [44].”
BackgroundO'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448 · cited 1×
“In one study, a blood pressure (BP) of at least 160/90 mmHg and a history of hypertension were considered equally important predispositions for stroke, with 54% of the stroke-affected population having these characteristics [42,43].”
BackgroundJohnson, C. O., Nguyen, M., Roth, G. A., Nichols, E., Alam, T., Abate, D., Abd-Allah, F., Abdelalim, A., Abraha, H. N., Abu-Rmeileh, N. M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30034-1 · Cited by 3,264 · cited 3×
“Primary (first-time) hemorrhages comprise the majority of strokes, with secondary (second-time) hemorrhages constituting an estimated 10–25% [2,3].”
BackgroundMethod
Research works printed but not linked: 2
- Rollin B.E. The Experimental Animal in Biomedical Research: Care, Husbandry and Well-Being: An Overview by Species Kesel M.L. CRC Press Boston, MA, USA 1995
- VE O.C. GA D. MR M. DW H. Animal models of stroke versus clinical stroke: Comparison of infarct size, cause, location, study design, and efficacy of experimental therapies Animal Models for the Study of Human Disease Michael Conn P. Academic Press Waltham, MA, USA 2013 531 568
Cited by
Items 301–400 of 1,001
Hanifa, M., Suri, M., Singh, H., Gagnani, R., Jaggi, A. S., & Bali, A. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04221-5 · Cited by 13
“Excessive calcium and excitotoxicity are also critical factors in ischemic stroke [4].”
Wu, M., Dewi, S. R. K., Hsu, W., Hsu, T.-Y., Liao, S.-F., Chan, L., & Lin, M. (2024) · Diagnostics · doi:10.3390/diagnostics14121304 · Cited by 13
“Ischemic stroke is the most common form of stroke, with approximately 87% of prevalence [1].”
BackgroundChen, J., Tan, B., Chen, Y., Song, Y., Li, L., Yu, L., Feng, Y., Zhou, Y., & Jiang, W. (2024) · Scientific Reports · doi:10.1038/s41598-024-69345-z · Cited by 14
Amygdalin's neuroprotective effects on acute ischemic stroke in rats.
Kimura, K., Liu, Y.-H., & Hsieh, C.-L. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119621 · Cited by 12
Cell membrane-coated nanoparticles for neurodegenerative disorders management
Thakur, N., Kumar, T., Singh, C., Kumar, A., & Kumar, A. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125875 · Cited by 14
Mao, H., Dou, W., Chen, K., Wang, X., Wang, X., Guo, Y., & Zhang, C. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103021 · Cited by 13
Risk of Stroke in Migrainous Women, a Hidden Association: A Systematic Review
Saddik, S. E., Dawood, S. N., Rabih, A. M., Niaj, A., Raman, A., Uprety, M., Calero, M. J., Villanueva, M. R. B., Joshaghani, N., Villa, N., et al. (2022) · Cureus · doi:10.7759/cureus.27103 · Cited by 12
“A link between migraine and hemorrhagic stroke is possible; while some studies have found no link, there is growing evidence that it is especially in women under 45 years old [33,34].”
BackgroundPlant based food bioactives: A boon or bane for neurological disorders
Choudhary, N., Tewari, D., Nabavi, S. F., Kashani, H. R. K., Lorigooini, Z., Filosa, R., Badrealam, K. F., Masoudian, N., & Nabavi, S. M. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2131729 · Cited by 12
“…loss of homeostasis, acidosis, excitotoxicity, increased intracellular calcium levels, free radical-mediated toxicity, complement activation, cytokine-mediated cytotoxicity, impairment of the blood-brain barrier, activation of glial cells, and infiltration of leukocytes (Kuriakose and Xiao 2020).”
BackgroundNezhad, N. J., Safari, A., Namavar, M. R., Nami, M., Karimi‐Haghighi, S., Pandamooz, S., Dianatpour, M., Azarpira, N., Khodabandeh, Z., Zare, S., et al. (2023) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2023.107202 · Cited by 11
Lumen segmentation using a Mask R-CNN in carotid arteries with stenotic atherosclerotic plaque
Kiernan, M., Mukaddim, R. A., Mitchell, C., Maybock, J., Wilbrand, S. M., Dempsey, R. J., & Varghese, T. (2023) · Ultrasonics · doi:10.1016/j.ultras.2023.107193 · Cited by 11
Cui, W., Hao, Y., Wang, M., Zhang, Q., Wang, J., Wei, G., & Hou, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7013299 · Cited by 12
“Although the morbidity, mortality, and recurrence rates of stroke have decreased over the past few decades, stroke is still the second leading cause of death and contributor to disability globally [1].”
BackgroundFernández, D., Pujol-Fuentes, C., Ruber, C., Calvo, S., Levin, M. F., Herrero, P., & Gómez-Trullén, E. M. (2022) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2022.00024 · Cited by 11
“According to the Global Burden of Disease Study (GBD) [2], the socioeconomic burden of stroke has increased over time, although there has been a decrease in its prevalence [3].”
MethodChen, Y., Yang, B., Liu, Y., Xu, L., Shi, Z., Liu, Y., Han, R., Yuan, F., Ouyang, J., Yan, X., et al. (2022) · High Voltage · doi:10.1049/hve2.12267 · Cited by 10
Connecting the Dots: The Interplay Between Stroke and the Gut-Brain Axis
Murthy, P. M., Jayashankar, C. A., Kandi, V., Reddy, M. K., Harikrishna, G. V., Reddy, K., Jp, R., Reddy, A. N., & Narang, J. (2023) · Cureus · doi:10.7759/cureus.37324 · Cited by 12
“On the other hand, hemorrhagic stroke is caused by bleeding in the brain [8].”
BackgroundCoppi, E., Cherchi, F., & Gibb, A. J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.375309 · Cited by 10
“…and a leading cause of disability worldwide (Paul and Candelario-Jalil, 2021) but few therapeutic options are available (Campbell et al., 2019; Kuriakose and Xiao, 2020) and the only Food and Drug Administration-approved drug is the thrombolytic enzyme tissue plasminogen activator to be…”
BackgroundTGR5 signalling in heart and brain injuries: focus on metabolic and ischaemic mechanisms
Xu, N., He, Y., Zhang, C., Zhang, Y., Cheng, S., Deng, L. Q., 田中, 義., Liao, B., Wei, Y., & Feng, J. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106428 · Cited by 13
“For example, TGR5 signalling antagonises NF-κ B by reducing phosphorylation of I κ B α , nuclear translocation of p65, and NF-κ B DNA binding activity (Xiao et al., 2020; Pols et al., 2011).”
Francisco, V., Louis, F., Billot, M., Bourvellec, M. L., Decatoire, A., David, R., & Bidet-Ildei, C. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105826 · Cited by 11
“Hence, employing AOT could be particularly beneficial for rehabilitating patients who present both motor and language disorders, which is often the case for individuals following a stroke (Kuriakose and Xiao, 2020).”
Guan, X., Zhu, Q., & Qian, H. (2024) · Topics in Stroke Rehabilitation · doi:10.1080/10749357.2024.2417646 · Cited by 10
Burma, J. S., Oni, I. K., Lapointe, A. P., Rattana, S., Schneider, K., Debert, C. T., Smirl, J. D., & Dunn, J. F. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120910 · Cited by 13
“A second condition where this multimodal approach holds promise is following ischemic stroke to identify the extent of physiological impairment (Koton et al., 2022; Kuriakose and Xiao, 2020).”
BackgroundBartoli, D., Lombardi, E., Trotta, F., Macripo, S., Pucciarelli, G., & Petrosino, F. (2024) · Journal of Clinical Nursing · doi:10.1111/jocn.17591 · Cited by 14
Ye, C., Mo, Y., Su, T., Huang, G., Lu, J., Tang, S., Huang, Q., Li, Q., Jiang, Q., Guo, F., et al. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1520298 · Cited by 11
Breaking Barriers in Stroke Therapy: Recent Advances and Ongoing Challenges
Bakka, A. G., Patil, S. S., Rachakonda, B., Patil, A., Bolleddula, J., Nandyala, P. S. K. R., Singamaneni, R., Sade, N., & Patnaik, P. K. (2025) · Cureus · doi:10.7759/cureus.78288 · Cited by 22
“It is primarily caused by arterial blockage, leading to significant neurological impairment and imposing a substantial burden on patients, families, and healthcare systems worldwide [1,2].”
Peng, Q., Wang, S., Huang, S., Deng, Y., Li, Z., Liu, C., Hong, Y., Duan, R., Xue, X., & Ge, P. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114150 · Cited by 12
Zhang, Z., Xue, X., Liu, P., Zhang, C., Li, J., Liu, Y., Jiang, Y., Lv, S., Wang, L., Zhou, H., et al. (2025) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2025.104712 · Cited by 15
Molecular Mechanisms of the Microbiota–Gut–Brain Axis in the Onset and Progression of Stroke
Caballero‐Villarraso, J., Pons-Villarta, S., Cruces-Párraga, J., Navarrete-Pérez, A., Camargo, A., Moreno, J. A., Túnez, I., & Agüera, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010071 · Cited by 11
“It is considered the most relevant risk factor for stroke, both for ischaemic stroke and intracerebral haemorrhage [70,71,75].”
InfluentialRahman, M. S., Esfahani, S. H., Nozohouri, S., Kumari, S., Kocot, J., Zhang, Y., Abbruscato, T. J., Karamyan, V. T., & Trippier, P. C. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128669 · Cited by 10
Yawoot, N., Chumboatong, W., Sengking, J., Tocharus, C., & Tocharus, J. (2022) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-022-00906-4 · Cited by 10
Kuttenreich, A., von Piekartz, H., & Heim, S. (2022) · Diagnostics · doi:10.3390/diagnostics12071721 · Cited by 13
You, J., Qian, F., Huang, Y., Guo, Y., Lv, Y., Yang, Y., Lu, X., Guo, T., Wang, J., & Gu, B. (2022) · Open Medicine · doi:10.1515/med-2022-0528 · Cited by 10
“Current treatment approaches for stroke mainly focus on stimulating nerve replacement and timely resolving the infarction to limit continuous hypoxic stressmediated damage, which eventually results in neuronal injury [4].”
BackgroundAnatomy of Cerebral Arteries with Clinical Aspects in Patients with Ischemic Stroke
Barbato, F., Allocca, R., Bosso, G., & Numis, F. G. (2022) · Anatomia · doi:10.3390/anatomia1020016 · Cited by 10
“[ 43].”
Fu, W., Tang, Y., Che, X., Tan, J., Ma, Y., & He, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1009169 · Cited by 10
“People have long searched for effective therapeutic agents that promote recovery in stroke patients (Kuriakose and Xiao, 2020).”
BackgroundBundled Approach to Improve Inpatient Stroke Recognition and Time to Treatment
Drollinger, L., & Prasun, M. A. (2022) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0000000000000685 · Cited by 10
Advances in Antibody-Based Therapeutics for Cerebral Ischemia
Sun, J., Yen, T., Jan, J., Mwale, P. F., Teng, R.-D., Taliyan, R., Hsieh, C.-T., & Yang, C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010145 · Cited by 12
“Other highlights of stroke include blood–brain barrier (BBB) damage, oxidative stress, cytokine-mediated toxicity, excitotoxicity, and loss of neuronal function [15].”
Gain‐of‐function of progesterone receptor membrane component 2 ameliorates ischemic brain injury
Zhou, C., Zhu, T., Ni, W., Zhou, H., Song, J., Wang, M., Jin, G., Zhou, Y., Han, J., & Hua, F. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14122 · Cited by 9
Stroke and systemic embolism in adult congenital heart disease
Prokšelj, K. (2023) · International Journal of Cardiology Congenital Heart Disease · doi:10.1016/j.ijcchd.2023.100453 · Cited by 13
Wu, C., Huang, H., Xu, W., Li, J., Chen, M., & Zhao, Q. (2023) · International Journal of Nursing Sciences · doi:10.1016/j.ijnss.2023.06.011 · Cited by 14
Isoflurane Anesthesia’s Impact on Gene Expression Patterns of Rat Brains in an Ischemic Stroke Model
Shpetko, Y. Y., Filippenkov, I. B., Denisova, A. E., Stavchansky, V. V., Gubsky, L. V., Limborska, S. A., & Dergunova, L. V. (2023) · Genes · doi:10.3390/genes14071448 · Cited by 11
“Impaired blood flow in the middle cerebral artery is considered the cause of a significant portion of all ischemic pathologies of the brain [6,7].”
BackgroundEffect of Air Pollution Particulate Matter on Ischemic and Hemorrhagic Stroke: A Scoping Review
Lamorie‐Foote, K., Ge, B. B., Shkirkova, K., Liu, Q., & Mack, W. J. (2023) · Cureus · doi:10.7759/cureus.46694 · Cited by 15
Guntupalli, C., Ponugoti, M., Prasanth, D., & Malothu, N. (2024) · Molecular Simulation · doi:10.1080/08927022.2024.2307530 · Cited by 10
How does biological sex affect the physiological response to nanomaterials?
Yang, J. J., Narayanamurthy, R., Yager, J. Y., & Unsworth, L. D. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101292 · Cited by 11
Zhou, B., Li, B., Feng, P., Wang, X., Gao, H., Xu, L., Wang, T., & Guo, X. (2022) · Folia Neuropathologica · doi:10.5114/fn.2022.117248 · Cited by 10
“Stroke is the second leading cause of death in the world [10].”
BackgroundCanillas, L., Soriano-Varela, A., Rodríguez-Campello, A., Steinhauer, E. G., Cuadrado‐Godia, E., & Broquetas, T. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1003878 · Cited by 12
“As previously reported (24, 42), in our cohort we have confirmed that the risk of stroke and its morbidity and mortality increases with age.”
ResultSärestöniemi, M., Myllymaki, S. K., Reponen, J., & Myllylä, T. (2023) · Finnish Journal of eHealth and eWelfare · doi:10.23996/fjhw.122743 · Cited by 13
Lipid engineered nanomaterials: A novel paradigm shift for combating stroke
Amulya, E., Bahuguna, D., Negi, M., Phatale, V., Sikder, A., Vambhurkar, G. B., Katta, C. B., Dandekar, M. P., Madan, J., & Srivastava, S. K. (2024) · Applied Materials Today · doi:10.1016/j.apmt.2024.102194 · Cited by 11
Fabrication of Shape Memory Polymer Endovascular Thrombectomy Device for Treating Ischemic Stroke
Kuram, E., & Karadeli, H. H. (2024) · Macromolecular Rapid Communications · doi:10.1002/marc.202400146 · Cited by 9
Ferreira, M., Carneiro, P., Costa, V. M., Carvalho, F. D., Meisel, A., & Capela, J. P. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0016 · Cited by 11
Chen, L., Gao, H., Wang, Z., Gu, B., Zhou, W., Pang, M., Zhang, K., Liu, X., & Ming, D. (2024) · Cognitive Neurodynamics · doi:10.1007/s11571-024-10143-8 · Cited by 13
Association between interleukin-6 levels and stroke: a systematic review and meta-analysis
Huang, X., Zhang, M., Wang, J., & Hu, F. (2024) · Journal of International Medical Research · doi:10.1177/03000605241274626 · Cited by 12
Aderinto, N., Olatunji, G. D., Kokori, E., Agbo, C. E., Babalola, A. E., Aboje, J. E., Edun, M. T., Oyelude, A. O., & Adejumo, F. A. (2025) · Current Treatment Options in Neurology · doi:10.1007/s11940-024-00823-5 · Cited by 9
“Beyond functional impairments, stroke-associated brain injuries lead to cognitive decline, depression, and substantial financial costs, emphasizing the need for effective rehabilitation strategies [6].”
Su, X., Zheng, B., Huang, H., Chen, S., Cao, M., & Chen, J. (2025) · Neurorehabilitation · doi:10.1177/10538135241304991 · Cited by 10
“Stroke is a localized brain dysfunction caused by acute cerebrovascular disease (Kuriakose & Xiao, 2020).”
Zhou, J., Li, C., Yu, Y., Kim, Y. K., & Park, S. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00135 · Cited by 10
Issa, E. H. B., Alghazo, E. M., Gharaibeh, R., Momani, N. B., Taha, D. Z., Jaradat, R. J., Alzu’bi, A., Almahasneh, F. A., Abu‐El‐Rub, E., & Al‐Zoubi, R. M. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf021 · Cited by 13
Split-belt treadmill training improves gait symmetry and lower limb function in patients with stroke
Wang, C., Zhang, Q., Hou, S., Guo, D., Han, X., Huo, W., & Zhang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-98322-3 · Cited by 9
Wu, J., Chen, X., Lin, X., Li, Z., Cao, Z., Huang, W., Shao, D., Hussain, S., Pu, K., & Zhao, N. (2025) · Physiological Research · doi:10.33549/physiolres.935458 · Cited by 9
Gao, J., Wang, L., Qin, M., Gao, Y., Sun, S., Hq, W., Gao, Q. F., & Yu, Y. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04472-1 · Cited by 11
“The routinely used thrombolytic reperfusion therapy invariably causes subsequent damage to ischemic brain tis - sue [4, 5 ].”
Robot-Assisted Therapy for Upper Limb Rehabilitation After Stroke: Umbrella Review
Liu, S., Zhang, X., Zhou, L., Zhang, J., Liu, J., & He, C. (2026) · Journal of Medical Internet Research · doi:10.2196/79363 · Cited by 10
“As one of the diseases with the highest disability rate worldwide, stroke severely affects upper limb motor function, significantly impacting patients’ ability to perform activities of daily living (ADL) and their quality of life [1].”
Choi, W.-H. (2022) · Healthcare · doi:10.3390/healthcare10030429 · Cited by 11
“A stroke interrupts the blood supply to the brain and causes bleeding in the brain tissue, leading to various types of neurological damage [30].”
BackgroundBrain’s Energy After Stroke: From a Cellular Perspective Toward Behavior
Mariman, J. J., Lorca‐Ponce, E., Biancardi, C. M., Burgos, P. I., & Álvarez‐Ruf, J. (2022) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2022.826728 · Cited by 9
“Until now, few studies have conclusive results related to the recovery of damaged tissue, however, some approaches shed light on which guidelines to follow to promote the recovery of metabolism after a stroke (Kuriakose and Xiao, 2020).”
BackgroundPre-clinical efficacy evaluation of human umbilical cord mesenchymal stem cells for ischemic stroke
Shen, D., Wang, H., Zhu, H., Jiang, C., Xie, F., Zhang, H., Lv, Q., Liu, Q., Wang, Z., Qi, N., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1095469 · Cited by 13
Станиславович, Д. С., Basalova, N. A., Primak, A. L., Balabanyan, V. Y., Efimenko, A. Y., Никитична, С. М., Popov, V. S., Velichko, A., Дмитриевич, Б. К., Akopyan, Z. A., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061608 · Cited by 11
“They may evoke damage to and death of neural cells [3,4] caused by ischemia, excitotoxicity, and toxic effects of blood (ferroptosis), as well as neuroinflammation, which leads to secondary injury to the brain tissue [26,27] and lesion expansion.”
BackgroundInfluentialGupta, M., Meghana, P. S., Reddy, K. H., & Supraja, P. (2023) · Communications in computer and information science · doi:10.1007/978-3-031-47055-4_10 · Cited by 15
Ahn, H., Lee, S., Jung, W. J., & Lee, K.-H. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i8.1151 · Cited by 9
Gopinath, G., Aslam, M., & Anusha, P. (2022) · Cureus · doi:10.7759/cureus.23625 · Cited by 9
“Stroke is a medical emergency characterised by abrupt neurological outburst due to impaired perfusion via the blood vessels of the brain [5].”
BackgroundThe Monocyte-to-Lymphocyte Ratio Predicts Acute Kidney Injury After Acute Hemorrhagic Stroke
Jiang, F., Liu, J., Yu, X., Li, R., Zhou, R., Ren, J., Liu, X., Zhao, S., & Yang, B. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.904249 · Cited by 11
Zhang, S., Huang, S., Hu, D., Jiang, F., Lv, Y., & Liu, G. (2022) · Cardiovascular Therapeutics · doi:10.1155/2022/3328574 · Cited by 11
“Stroke is a disease caused by brain damage due to the interruption of the blood supply to the brain [1, 2].”
BackgroundCmPn/CmP Signaling Networks in the Maintenance of the Blood Vessel Barrier
Gnanasekaran, R., Aickareth, J., Hawwar, M., Sanchez, N., Croft, J., & Zhang, J. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13050751 · Cited by 9
Farzaneh, M., Anbiyaee, O., Azizidoost, S., Nasrolahi, A., Ghaedrahmati, F., Kempisty, B., Mozdziak, P. E., Khoshnam, S. E., & Najafi, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03740-x · Cited by 9
“The pathophysiological consequences of stroke can lead to neuronal cell death and brain damage, and current therapeutic approaches are limited to tissue plasminogen activator (tPA)-induced reperfusion and mechanical thrombectomy [5, 6].”
Korupolu, R., Malik, A., Ratcliff, C., Robinson-Whelen, S., & Taylor, H. B. (2022) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2022.05.020 · Cited by 8
Dong, H., Ma, Y., Cui, M.-M., Qiu, Z.-H., He, M., & Zhang, B. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13252 · Cited by 8
“In the event of cerebral hemorrhage, blood vessels rupture, leading to the release of a substantial amount of blood and hemoglobin (43).”
BackgroundMa, X.-Y., Qi, C.-Y., Xu, X.-Y., Li, H., Liu, C., Wen, X., Fu, Y., Liu, Y., Liang, J., Huang, C.-Y., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04247-9 · Cited by 9
“Stroke is the most prevalent cerebrovascular disease world-wide and remains a leading cause of death and long-term disability [1–3], especially in elderly individuals.”
Shi, Y., Bao, L., Li, Y., Ou, D., Li, J., Liu, X., Deng, N., Deng, C.-Q., Huang, X., Zhang, W., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.182 · Cited by 11
Kaur, M., Aran, K. R., & Paswan, R. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06708-4 · Cited by 8
“Ischemic Stroke occurs when a section of the brain experi - ences suspended blood supply due to narrowing or block - age of arteries (Kuriakose et al. 2020 ).”
Gulati, A., Adwani, S., Pamidimukkala, V., Agrawal, N. R., Ramakrishnan, T., Rai, H. P., Jain, D., Nagarjunakonda, S., Pandian, J. D., Sardana, V., et al. (2024) · Drugs · doi:10.1007/s40265-024-02121-5 · Cited by 8
“It affects nearly 13.7 million people yearly, and about 5.5 million people do not survive [2].”
InfluentialTian, A., Zheng, Y., Jin, J., & Huang, C.-Y. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1538352 · Cited by 9
Wang, H., Guo, J., Zhang, Y., Fu, Z. Q., & Yao, Y. (2025) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-025-01617-9 · Cited by 9
“K [17]. and Seyed.”
Decoding hippocampal subfield and glial responses in ischemia using single-cell transcriptomics
Kwak, D., Park, J.-H., Kim, Y. H., & Yoo, H. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06738-2 · Cited by 9
“Despite the critical need to understand the risk factors involved in the pathophysiological processes within the neurovascular unit that lead to neuronal damage, significant clinical advancements in interventions to alleviate ischemia mechanism have not been achieved [1].”
Mondal, V., Ross-Munro, E., Balasuriya, G. K., Kumari, R., Hossen, M. M., Ageeli, M., Firipis, K., Nisbet, D. R., King, G. F., Williams, R. J., et al. (2025) · Cells · doi:10.3390/cells14120910 · Cited by 11
“…due to the delay in diagnosis in neonates, which is typically many hours or even a day or more, it is not feasible to focus on the restoration of blood flow, and the interventions that work in adults (clot removal and thrombolytics) are of high risk and not established in small infants [74].”
Hao, Y.-X., Li, C., Lu, Z., Kong, N., Huang, R.-H., Ma, S., Zhou, W.-F., Jiao, H., Qiu, Y., Yu, Y.-F., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06736-4 · Cited by 12
“Glutamate receptors contribute to neuronal damage via excitotoxicity and depolarization, owing to the untimely release of glutamate [56], drugs have been developed in recent years to target the pathway down-stream of the receptor (N-methyl-d-aspartic acid receptor [NMDAR]-associated signalling…”
Alabdali, M. M., Alrasheed, A. S., Alghirash, F. A., Almaqboul, T. M., Alhashim, A., Aljaafari, D., & AlQarni, M. (2025) · Biomedicines · doi:10.3390/biomedicines13081834 · Cited by 12
He, J., Jin, S., Fan, W., Wu, L., Gopinath, S. C. B., & Hu, Z. (2022) · Process Biochemistry · doi:10.1016/j.procbio.2022.01.013 · Cited by 8
Kim, J., Song, J., Kim, D., & Park, J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095022 · Cited by 10
“Stroke is a disease caused by blocked or ruptured blood vessels that supply oxygen and nutrients to the brain and is a major risk factor for death and disability [6].”
BackgroundNing, K., & Gao, R. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11849 · Cited by 8
“Neurological disorders are the leading cause of disability and the second leading cause of death worldwide, and ischemia is one of the major causes of stroke leading to neurological disorders (1,2).”
BackgroundFang, M., Wang, J., Wang, Z., Chen, Y., Xu, W., Tao, C., Lu, M., You, C., Hu, X., & Xia, F. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1097183 · Cited by 9
“The main findings of this study are as follows: (1) Among pregnancyassociated HS patients, the long-term functional outcomes of patients diagnosed with HDP were significantly poorer; (2) HDP”
BackgroundResultInfluentialWaseem, A., Rashid, S., Rashid, K., Khan, M. A., Khan, R., Haque, R., Seth, P., & Raza, S. S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.04.006 · Cited by 8
Chen, M., Fan, L., Wu, G., Wang, H., & Gu, S. (2023) · Environmental Toxicology · doi:10.1002/tox.23863 · Cited by 9
Shared Decision-Making to Improve Health-Related Outcomes for Adults with Stroke Disease
Băjenaru, L., Sorici, A., Mocanu, I. G., Florea, A. M., Antochi, F. A., & Ribigan, A. C. (2023) · Healthcare · doi:10.3390/healthcare11121803 · Cited by 11
“Digital technology has enormous potential to transform clinical research and care in neurological diseases [10,11].”
BackgroundZhang, X., Ma, L., Liu, M., Zhu, T., Huang, Z., Xiong, Y., Wang, Z., & Shi, J. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148477 · Cited by 8
“Currently, intravenous thrombolysis is the most effective treatment for patients with ischemic stroke (Kuriakose and Xiao, 2020; Barthels and Das, 2020).”
Mbonde, A. A., Young, M. J., Dmytriw, A. A., Moyer, Q., Hirsch, J. A., Leslie‐Mazwi, T. M., Rost, N. S., Patel, A. B., & Regenhardt, R. W. (2023) · Journal of Neurology · doi:10.1007/s00415-023-12028-y · Cited by 8
“The primary objective of acute stroke treat-ment is to promptly restore blood flow to the affected brain region [11, 13, 14].”
ÖZTÜRK, S., Aydoğdu, O., & Sarı, Z. (2024) · Topics in Stroke Rehabilitation · doi:10.1080/10749357.2024.2310425 · Cited by 8
Halawani, A., Aljabri, A., Bahathiq, D. M., Morya, R. E., Alghamdi, S., & Makkawi, S. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1340248 · Cited by 9
Sardar, M. B., Raza, M., Fayyaz, A., Nadir, M. A., Nadeem, Z. A., & Babar, M. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09913-x · Cited by 10
Gai, K., Yang, M., Chen, W., Hu, C., Luo, X., Smith, A. G., Xu, C., Zhang, H., Li, X., Shi, W., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401419 · Cited by 10
Xun, X., Liu, Y., Pan, W., Tang, L., Hu, C., Ouyang, H., Liu, Q., Zeng, H., & Li, D. (2024) · Psychogeriatrics · doi:10.1111/psyg.13199 · Cited by 9
Khorsand, B., Vaghf, A., Salimi, V., Zand, M., & Ghoreishi, S. A. (2025) · Brain Injury · doi:10.1080/02699052.2025.2472188 · Cited by 14
“This condition arises from the sudden death of brain tissue due to a dramatic reduction in blood flow and oxygen supply to the brain, often caused by the formation of clots and occlusion of cerebral arteries (3).”
Cerebral Damage after Stroke: The Role of Neuroplasticity as Key for Recovery
Muhammad, M., & Hassan, T. M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95512 · Cited by 10
Wattoo, M. A., Tabassum, M., Bhutta, K. R., Rafi, Z., Kaneez, M., Razzaq, M. T., Rizwan, R., Sarwar, Z., Sajid, M. U., & Bhutta, F. R. (2021) · Cureus · doi:10.7759/cureus.15214 · Cited by 8
“5 million individuals succumb to its complications [3,4].”
BackgroundPharmacotherapeutic Potential of Garlic in Age-Related Neurological Disorders
Ahangar‐Sirous, R., Poudineh, M., Ansari, A., Nili, A., Dana, S. M. M. A., Nasiri, Z., Hosseini, Z., Karami, D., Mokhtari, M., & Deravi, N. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210927101257 · Cited by 9
Metabolomics of neurological disorders in India
Gupta, S., & Sharma, U. (2021) · Analytical Science Advances · doi:10.1002/ansa.202000169 · Cited by 9
“82,83 Currently available limited unsatisfactory therapeutic options for acute stroke, include intravenous recombinant tissue plasminogen activator, with a narrow therapeutic time window of only 4.5 h along with a risk of haemorrhagic transformation and intra-arterial devices initiation within 6 h…”
BackgroundInfluentialSertad1 Induces Neurological Injury after Ischemic Stroke via the CDK4/p-Rb Pathway
Li, J., Li, B., Bu, Y., Zhang, H., Guo, J., Hu, J., & Zhang, Y. (2022) · Molecules and Cells · doi:10.14348/molcells.2021.0071 · Cited by 8
“Cerebral ischemia accounts for 87% of all stroke cases and is one of the leading causes of death and disability globally (Kuriakose and Xiao, 2020; Russo et al., 2011).”
BackgroundDera, H. S. A., Alassiri, M., Alkahtani, R., Eleawa, S. M., AlMulla, M. K., & Alamri, A. S. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2022.01.018 · Cited by 9
Metadata
- Authors
- Kuriakose, D., & Xiao, Z.
- Affiliations
- Monash University (AU)
- Development and Stem Cells Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC 3800, Australia
- ORCID
- Kuriakose, Diji
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-10-15
- Volume
- 21
- Issue
- 20
- Pages
- 7609
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7589849
- OpenAlex
- W3093285665
- Semantic Scholar
- f44478fa13b48c2e68d010e69172d6d21ab09e66
- Cited by
- 1,350
- References
- 189
- Citations by year
- 2026: 154 · 2025: 291 · 2024: 346 · 2023: 300 · 2022: 196 · 2021: 63
- FWCI
- 20.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Apex Biotech Research (NA)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Keywords
- stroke, ischemic stroke, stroke pathophysiology, stroke treatment, reperfusion therapy, neurological damage, animal models of stroke, stroke rehabilitation, stroke prevention, therapeutic target, post-stroke care
- MeSH terms
- Stroke Rehabilitation, Animals, Fibrinolytic Agents, Humans, Risk Factors, Neuroprotective Agents, Stroke, Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


